Sort   by:  
 Page size 
UnknownGliflozins, sucrose and flavonoids are allosteric activators of lecithin-cholesterol acyltransferase.
Not available
S-EPMC11525561 | biostudies-literature
UnknownMeta-analyzing the factors affecting the efficacy of gliflozins in patients with heart failure based on heart failure trials.
Not available
S-EPMC8284750 | biostudies-literature
UnknownGliflozins for the prevention of stroke in diabetes and cardiorenal diseases: A meta-analysis of cardiovascular outcome trials.
Not available
S-EPMC8483857 | biostudies-literature
UnknownGliflozins Have an Anti-Inflammatory Effect on Renal Proximal Tubular Epithelial Cells in a Diabetic and Inflammatory Microenvironment In Vitro.
Not available
S-EPMC9916320 | biostudies-literature
ProteomicsMetabolic reconfiguration through SGLT2 inhibition improves metabolic waste excretion
Dapagliflozin is a member of a new class of medication called gliflozins indicated for the treatment of diabetes and has recently been also approved for the treatment of kidney and heart diseases. Gliflozins lower blood glucose levels by inhibition of the sodium glucose co-transporter 2 (SGLT2), whi...
ORGANISM(S): Mus musculus (Mouse) mouse gut metagenome 
2026-02-09 | PXD036817 | Pride
White adipose tissue Kidney Heart Skeletal muscle Lc-ms/ms Dapagliflozin Mouse Tmt Exploris 480 Murine Sglt2 inhibitors Liver Gut microbiome 
UnknownThe Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors Reduce Platelet Activation and Thrombus Formation by Lowering NOX2-Related Oxidative Stress: A Pilot Study.
Not available
S-EPMC9598474 | biostudies-literature
UnknownA Description of Acute Renal Failure and Nephrolithiasis Associated With Sodium-Glucose Co-Transporter 2 Inhibitor Use: A VigiBase Study.
Not available
S-EPMC9393368 | biostudies-literature
UnknownCardiovascular outcomes in patients treated with sodium-glucose transport protein 2 inhibitors, a network meta-analysis of randomized trials.
Not available
S-EPMC9760750 | biostudies-literature
UnknownSAVOR-TIMI to DECLARE-TIMI: A Review on Cardiovascular Outcome Trials of Incretin-modulators and Gliflozins.
Not available
S-EPMC6540886 | biostudies-literature
UnknownNo Cytotoxic and Inflammatory Effects of Empagliflozin and Dapagliflozin on Primary Renal Proximal Tubular Epithelial Cells under Diabetic Conditions In Vitro.
Not available
S-EPMC7013746 | biostudies-literature
Sort   by:  
 Page size